Bio-Techne Corporation Forecast, price target & analysts
Bio-Techne Corporation Target price 2026 - Analyst rating & recommendation
Bio-Techne Corporation Classifications & Recommendation
Bio-Techne Corporation Price Target
| Target Price | $74.46 |
| Price | $72.40 |
| Potential |
2.85%
register free of charge
|
| Number of Estimates | 16 |
|
16 Analysts have issued a price target Bio-Techne Corporation 2027 .
The average Bio-Techne Corporation target price is $74.46.
This is
2.85%
register free of charge
$82.95
14.57%
register free of charge
$50.50
30.25%
register free of charge
|
|
| A rating was issued by 22 analysts: 7 Analysts recommend Bio-Techne Corporation to buy, 15 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Bio-Techne Corporation stock has an average upside potential 2027 of
2.85%
register free of charge
|
Sales and Margin forecast 2027, 2028 to 2030
| Jun '26 |
2027 Estimates |
|
|---|---|---|
| Revenue Billion $ | 1.22 | 1.29 |
| 0.38% | 6.42% | |
| EBITDA Margin | 24.98% | 35.78% |
| 2.68% | 43.26% | |
| Net Margin | 14.97% | 25.08% |
| 148.81% | 67.58% |
16 Analysts have issued a sales forecast Bio-Techne Corporation 2027 . The average Bio-Techne Corporation sales estimate is
This results in the following potential growth metrics:
13 Analysts have issued an Bio-Techne Corporation EBITDA forecast 2027. The average Bio-Techne Corporation EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
18 Bio-Techne Corporation Analysts have issued a net profit forecast 2027. The average Bio-Techne Corporation net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2027, 2028 to 2030
| Jun '26 |
2027 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 1.16 | 2.08 |
| 152.17% | 79.31% | |
| P/E | 34.85 | |
| EV/Sales | 8.73 |
18 Analysts have issued a Bio-Techne Corporation forecast for earnings per share. The average Bio-Techne Corporation EPS is
This results in the following potential growth metrics and future valuations:
Bio-Techne Corporation...
Current Bio-Techne Corporation Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Wells Fargo |
Locked
➜
Locked
|
Locked | Aug 13 2026 |
| RBC Capital |
Locked
➜
Locked
|
Locked | Jul 09 2026 |
| Benchmark |
Locked
➜
Locked
|
Locked | Jun 30 2026 |
| TD Cowen |
Locked
➜
Locked
|
Locked | Jun 30 2026 |
| Citigroup |
Locked
➜
Locked
|
Locked | Jun 29 2026 |
| Stephens & Co. |
Locked
➜
Locked
|
Locked | Jun 26 2026 |
| Baird |
Locked
➜
Locked
|
Locked | Jun 26 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
Wells Fargo:
Locked
➜
Locked
|
Aug 13 2026 |
|
Locked
RBC Capital:
Locked
➜
Locked
|
Jul 09 2026 |
|
Locked
Benchmark:
Locked
➜
Locked
|
Jun 30 2026 |
|
Locked
TD Cowen:
Locked
➜
Locked
|
Jun 30 2026 |
|
Locked
Citigroup:
Locked
➜
Locked
|
Jun 29 2026 |
|
Locked
Stephens & Co.:
Locked
➜
Locked
|
Jun 26 2026 |
|
Locked
Baird:
Locked
➜
Locked
|
Jun 26 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
